IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 415.87 USD -1.58% Market Closed
Market Cap: 33.8B USD

During the last 3 months IDEXX Laboratories Inc insiders have not bought any shares, and sold 6m USD worth of shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Feb 10, 2025 by Fennell George (Corporate Vice President) , who sold 4.6m USD worth of IDXX shares.

Last Transactions:
Fennell George
Corporate Vice President
$-4.6m
Szostak M Anne
Director
$-1.4m
Vandebroek Sophie V.
Member of the Board of Directors
$-144.6k
Szostak M Anne
Director
$-234.7k
Claflin Bruce L.
Independent Chairman of the Board
$-108.2k
Polewaczyk James F
Executive Vice President (EVP) and Head of Companion Animal Group Commercial Operations
$-2.3m
Vandebroek Sophie V.
Member of the Board of Directors
$-790.4k
Fennell George
Corporate Vice President
$-691.7k
Mazelsky Jonathan Jay
President and Chief Executive Officer
$-3.1m
Mckeon Brian P
Executive Vice President and Chief Financial Officer
$-346.7k
Polewaczyk James F
Executive Vice President (EVP) and Head of Companion Animal Group Commercial Operations
$-1.6m
Mazelsky Jonathan Jay
President and Chief Executive Officer
$-3m
Mazelsky Jonathan Jay
President and Chief Executive Officer
$-6.9m
Polewaczyk James F
Executive Vice President (EVP) and Head of Companion Animal Group Commercial Operations
$-254.5k
Lane Michael
Corporate Vice President, General Counsel and Corporate Secretary
$-8.2m
Ayers Jonathan W
Chairman of the Board
$-486.5k
Szostak M Anne
Director
$-331.5k
Lane Michael
Corporate Vice President, General Counsel and Corporate Secretary
$-484k
Vandebroek Sophie V.
Member of the Board of Directors
$-1m
Junius Daniel M
Principal Scientist
$-1.1m
Turner Kathy V
Chief Financial Officer
$-510k
Turner Kathy V
Chief Financial Officer
$-505.1k
Turner Kathy V
Chief Financial Officer
$-505k
Junius Daniel M
Principal Scientist
$-1.3m
Szostak M Anne
Director
$-317.1k
Turner Kathy V
Chief Financial Officer
$-1.3m
Mazelsky Jonathan Jay
President and Chief Executive Officer
$-421.2k
Turner Kathy V
Chief Financial Officer
$-1.1m
Mazelsky Jonathan Jay
President and Chief Executive Officer
$-340.7k
Ayers Jonathan W
Chairman of the Board
$-127.4k
Polewaczyk James F
Executive Vice President (EVP) and Head of Companion Animal Group Commercial Operations
$-2.9m
Mckeon Brian P
Executive Vice President and Chief Financial Officer
$-4.3m
View All Transactions

During the last 3 months IDEXX Laboratories Inc insiders have not bought any shares, and sold 6m USD worth of shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Feb 10, 2025 by Fennell George (Corporate Vice President) , who sold 4.6m USD worth of IDXX shares.

Sold
0-3
months
6m USD
2
3-6
months
144.6k USD
1
6-9
months
234.7k USD
1
9-12
months
108.2k USD
1
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

IDEXX Laboratories Inc
Insider Trading Chart

IDEXX Laboratories Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

IDEXX Laboratories Inc
Last Insider Transactions

Global
Insiders Monitor

IDEXX Laboratories Inc
Glance View

Economic Moat
Narrow
Market Cap
33.9B USD
Industry
Health Care

IDEXX Laboratories Inc. stands as a pillar of innovation in the realm of veterinary diagnostics, transforming the landscape of animal healthcare. Founded in 1983, the company has strategically positioned itself at the intersection of science and care, delivering a broad range of products and services that cater primarily to veterinarians. By offering state-of-the-art diagnostic tests and in-house laboratory equipment, IDEXX empowers veterinarians to make precise and timely decisions. These tools not only enhance animal health but also streamline veterinary practices, allowing them to offer clients rapid, reliable results. By investing heavily in research and development, IDEXX continuously enhances its product portfolio, maintaining a competitive edge in a market that demands constant innovation. In addition to its core veterinary diagnostic services, IDEXX extends its expertise into water testing and livestock and poultry diagnostics, though these segments are smaller. The company crafts its revenue model on providing recurring, subscription-based services for its diagnostic machines, which require regular updating with new test kits and consumables. This model ensures a durable revenue stream, fostering long-term relationships with veterinary clinics worldwide. As digital transformation sweeps through every industry, IDEXX has also embraced the digital age, crafting sophisticated software that aids veterinarians in managing their practices more efficiently, thus augmenting its revenue through IT solutions. This diversified yet synergistic approach has allowed IDEXX to remain resilient and grow steadily, delivering consistent value to both its clients and shareholders.

IDXX Intrinsic Value
269.13 USD
Overvaluation 35%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top